This indicates that the individual MMP/TIMP composition at the leading edge of each tumor might create a fine-tuned microenvironment irrespective of (and of higher prognostic relevance than) expression of one MMP or baseline oncogenic mutations, such as KRAS or BRAF. Here, BRAF is linked to neoplasm.